In addition, inhibition of TAK1 binding to TRAF6 has been shown to inhibit TAK1 mediated JNK1/2 and p38 signaling and subsequently inhibiting cardiac hypertrophy both in vivo and in vitro (Ji et al., 2016). This evidence concerns the gene MAPK8 and cardiac hypertrophy.